ASX:RMDHealth Care Equipment & ServicesHealth Care Equipment

RESMED CDI

$35.410

+$0.420 (+1.20%)

Day Range

$35.410 - $35.920

52 Week Range

$32.040 - $45.250

Volume

2.16M

Market Cap

$20.56B

Price Chart

Market Statistics

Open$35.710

Previous Close$34.990

Day High$35.920

Day Low$35.410

52 Week High$45.250

52 Week Low$32.040

Valuation

Market Cap20.56B

Shares Outstanding580.55M

Trading Activity

Volume2.16M

Value Traded76.79M

Bid$35.300 × 200

Ask$35.600 × 1,406

Technical Indicators

RSI (14)44.24

50-Day SMA$36.736

200-Day SMA$39.341

Weekly Wrap: Late pullback slams gold shares

ASX slips 0.7% as late pullback drags gold shares lower on Fed chair speculation; bullion drops ~5% amid rate-hike fears.

4 min read

John Beveridge

ASX 200Biotechnology

ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices

ResMed (ASX: RMD) has reported double-digit earnings per share (EPS) growth for the three months to March on the back of increasing market demand for its best-in-class sleep apnoea products and software solutions. The company’s revenue for the period increased by 8% to US$1.3 billion (up 9% on a constant currency basis), while income from […]

2 min read

Imelda Cotton

ASX 200Technology

ResMed shares hit as Eli Lilly’s weight loss drug demonstrates sleep apnoea benefits

Medical device maker ResMed (ASX: RMD) saw its shares tumble more than 13% after pharmaceutical rival Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) could also help resolve sleep apnoea in some patients. California-based ResMed is a giant in the sleep apnoea space, manufacturing face masks, nasal devices and continuous positive airway pressure (PAP) […]

2 min read

Imelda Cotton